货号:A256874
同义名:
Cardamomin; Alpinetin chalcone
Cardamonin是一种从草豆蔻(Alpinia katsumadai Hayata)中分离的天然黄酮,作为芳基碳氢化合物受体(AhR)激活剂。Cardamonin通过AhR/Nrf2/NQO1途径抑制NLRP3炎性小体活化,从而缓解炎症性肠病。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | AhR ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| StemRegenin 1 |
++
Aryl hydrocarbon receptor (AhR), IC50: 127 nM |
99%+ | |||||||||||||||||
| CH-223191 |
+++
AhR, IC50: 30 nM |
99%+ | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 描述 | Cardamonin, a chalcone extracted from cardamom spice with anti-inflammatory and anti-tumor activities. Cardamonin decreased viability of NPC(Nasopharyngeal carcinoma ) cells in a concentration-dependent manner. The IC50 values were 16.22 μM(CNE-1), 14.34 μM (CNE-2), 16.50 μM (HONE-1), and 68.12 μM (SUNE-1). Moreover, the expression level of the proapoptotic effector protein Bax and Bid was also markedly increased after treatment with cardamonin(15μM) in CNE-2 cells. In vivo, cardamonin (25 mg/kg once every other day from days 13) enhances chemotherapy efficacy. |
| Concentration | Treated Time | Description | References | |
| MDA-MB-231 cells | 20 μM | 2, 4, 6 h | Cardamonin increased ROS levels in MDA-MB-231 cells | J Exp Clin Cancer Res. 2019 Aug 27;38(1):377. |
| MDA-MB-231 cells | 20 μM | 6 h | Cardamonin decreased glucose uptake in MDA-MB-231 cells | J Exp Clin Cancer Res. 2019 Aug 27;38(1):377. |
| MDA-MB-231 cells | 20 μM | 3, 6, 12 h | Cardamonin enhanced mitochondrial oxidative phosphorylation in MDA-MB-231 cells | J Exp Clin Cancer Res. 2019 Aug 27;38(1):377. |
| RAW 264.7 cells | 10, 20, 30 µM | 24 h | Cardamonin inhibited nitric oxide production in LPS-stimulated RAW 264.7 cells without affecting cell viability. | Biomolecules. 2021 Apr 29;11(5):661. |
| THP-1 cells | 20 µM | 24 h | Conditioned medium from cardamonin-pre-treated THP-1 cells did not increase the proliferation of HCT116 cells. | Biomolecules. 2021 Apr 29;11(5):661. |
| Nf1-silenced murine GBM cells | 10 and 20 μM | 24 and 48 h | To evaluate the effect of Cardamonin on NF-κB phosphorylation, results showed that Cardamonin treatment did not reduce NF-κB phosphorylation | J Clin Invest. 2023 Nov 15;133(22):e163802. |
| THP-1 induced macrophages | 10 µM and 20 µM | 24 h | Cardamonin suppressed M2 polarization of TAMs and downregulated TAM-secreted tumorigenic factors, thereby hindering the pro-tumor function of TAMs on ovarian cancer cells. | Mol Ther Oncolytics. 2022 Jun 25;26:175-188. |
| SKOV3 and A2780 cells | 0, 10, 20, 30, 40, 50 µM | 24 h | Cardamonin inhibited the cell viability of SKOV3 and A2780 cells in a concentration-dependent manner. | Mol Ther Oncolytics. 2022 Jun 25;26:175-188. |
| SUM190 | 10 μM | 4 days | Cardamonin inhibited the formation of mammosphere-like structures induced by poly(I:C) and suppressed the nuclear translocation of NF-κB and β-catenin. | Cell Death Differ. 2015 Feb;22(2):298-310. |
| SUM190 | 10 μM | 4 days | Cardamonin inhibited the increase in the CD44high/CD24−/low cell subpopulation induced by poly(I:C). | Cell Death Differ. 2015 Feb;22(2):298-310. |
| SUM190 | 10 μM | 4 days | Cardamonin inhibited the expression of Oct4, c-Myc, and CD44 induced by poly(I:C). | Cell Death Differ. 2015 Feb;22(2):298-310. |
| Administration | Dosage | Frequency | Description | References | ||
| ICR mice | Acute pain models | Intraperitoneal injection | 0.3, 1, 3, 10 mg/kg | Single administration | To investigate the antinociceptive effects of Cardamonin in acute pain models and its possible mechanisms. The results showed that Cardamonin significantly inhibited acetic acid-induced abdominal writhing and dose-dependently suppressed pain responses induced by PMA and glutamate. | Molecules. 2020 Nov 18;25(22):5385 |
| SCID mice | SUDHL-4 cell xenograft model | Intragastric administration | 15 mg/kg | Once per day for 30 days | To evaluate the in vivo anti-tumor effect of Cardamonin on RRAGC-mutant lymphoma, results showed that Cardamonin significantly inhibited tumor growth in RagCT90N-mutant SUDHL-4 cells. | BMC Complement Med Ther. 2023 Sep 26;23(1):336 |
| Nude mice | MDA-MB-231 xenograft model | Intraperitoneal injection | 3 mg/kg | Once daily for four weeks | Cardamonin significantly inhibited tumor growth in the MDA-MB-231 xenograft model | J Exp Clin Cancer Res. 2019 Aug 27;38(1):377. |
| C57Bl/6 mice | DSS-induced colitis model | Oral | 10 mg/kg, 50 mg/kg | Daily for 12 days | Cardamonin attenuated DSS-induced colitis and reduced the accumulation of inflammatory cells in the colon. | Biomolecules. 2021 Apr 29;11(5):661. |
| BALB/c nude mice | Xenograft model of SKOV3 cells or SKOV3 cells mixed with M2 macrophages | Intraperitoneal injection | 5 mg/kg and 25 mg/kg | Once daily for 15 days | Cardamonin significantly inhibited tumor growth and lowered the expression of CD163 and CD206. | Mol Ther Oncolytics. 2022 Jun 25;26:175-188. |
| Mice | CCI-induced neuropathic pain model | Intraperitoneal injection | 10 mg/kg | Single administration | Cardamonin significantly upregulated 5-HT1A receptor subtype expression in the brainstem and spinal cord, indicating its antineuropathic effect in CCI-induced neuropathic pain mice. | Molecules. 2021 Jun 16;26(12):3677 |
| Nude mice | SUM190 xenograft model | Intraperitoneal injection | 30 mg/kg | Every other day for 20 days | Cardamonin almost completely abolished the increase in CSCs induced by poly(I:C). | Cell Death Differ. 2015 Feb;22(2):298-310. |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
3.70mL 0.74mL 0.37mL |
18.50mL 3.70mL 1.85mL |
37.00mL 7.40mL 3.70mL |
|
| CAS号 | 18956-16-6 |
| 分子式 | C16H14O4 |
| 分子量 | 270.28 |
| SMILES Code | COC1=CC(O)=CC(O)=C1C(=O)C=CC1=CC=CC=C1 |
| MDL No. | MFCD00238554 |
| 别名 | Cardamomin; Alpinetin chalcone |
| 运输 | 蓝冰 |
| 存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 |
| 溶解方案 |
DMSO: 120 mg/mL(443.98 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1